SCHEMBL18347010

SCHEMBL18347010

Brc1cccc2c1ccc1c(-c3ccc4ccccc4c3)nc3ccccc3c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
BACE1 P56817 1/20 0.39
DHODH Q02127 1/20 0.37
ADORA2A P29274 4/20 0.37
ADORA1 P30542 2/20 0.37
TYMS P04818 2/20 0.36
HTR2B P41595 1/20 0.36
HTR5A P47898 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
MAPK10 P53779 1/20 0.35
GRM5 P41594 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18347005 0.89 ADORA2A (0.38) CYP1A2DHODHADORA2AADORA1HTR2B
SCHEMBL17035158 0.86 CYP1A2 (0.47) CYP1A2BACE1DHODHADORA2ATYMS
SCHEMBL18200645 0.86 MAPK8 (0.43) DHODHADORA2AADORA1HTR2BHTR5A
SCHEMBL18200633 0.84 MAPK8 (0.42) DHODHADORA2AADORA1HTR2BHTR5A
SCHEMBL18347047 0.83 BIRC5 (0.47) CYP1A2ADORA2AADORA1KDM4EMEN1
SCHEMBL18346929 0.83 MET (0.40) CYP1A2DHODHADORA2AADORA1ALDH1A1
SCHEMBL18200401 0.83 MET (0.40) CYP1A2DHODHADORA2AADORA1HTR2B
SCHEMBL21537832 0.82 CYP2A6 (0.43) CYP1A2KDM4EMEN1KMT2A
SCHEMBL18200400 0.82 MAPK8 (0.40) CYP1A2DHODHADORA2AADORA1HTR2B
SCHEMBL18200455 0.82 ADORA2A (0.39) CYP1A2DHODHADORA2AADORA1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 CYP1A2 134/4885BACE1 206/4885DHODH 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.